GleamWall
中文EN

BIOF BLUE BIOFUELS, INC.

Industrial Organic Chemicals · OTC · SEC CIK 1549145 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-21.1%
TTM EPS YoY-18.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-288.0%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets436.2%
Debt / equity—
Current ratio0.01x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.35x
Accruals ratio-187.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue————————
R&D expense$826,453$431,198$384,913$997,487$485,677$471,470$350,707$1.02M
SG&A expense$555,192$397,408$274,585$289,984$350,577$431,134$338,098$944,388
Operating income-$1.38M-$731,106-$659,498-$1.29M-$836,254-$902,604-$688,805-$1.96M
Interest expense$3,623$19,689$4,303—$6,323$18,148——
Net income-$1.39M-$750,795-$663,801-$1.29M-$422,547-$920,752-$243,833-$1.79M
EBITDA-$1.36M-$702,132-$628,121-$1.27M-$805,915-$872,406-$658,879-$1.93M
EPS (basic)-0.00-0.00-0.00—-0.00-0.00-0.00—
EPS (diluted)-0.00-0.00-0.00—-0.00-0.00-0.00—
Weighted avg. shares (diluted)324.06M321.22M319.23M—312.17M310.05M308.46M—
Balance sheet
Cash & equivalents$6,473$22,040$8,665$65,200$95,194$8,026$7,583$48,797
Current assets$18,524$34,091$20,216$76,751$106,645$19,478$40,072$81,286
PP&E, net$574,519$529,719$524,810$555,109$585,408$615,746$641,988$539,648
Intangibles$57,863$58,942$60,020$61,098————
Total assets$1.35M$1.32M$1.31M$1.41M$1.49M$1.45M$1.48M$1.39M
Current liabilities$3.68M$3.38M$3.12M$2.98M$2.39M$2.45M$2.33M$2.21M
Total liabilities$5.90M$5.38M$5.25M$5.11M$4.54M$4.62M$4.43M$4.24M
Shareholders' equity-$4.55M-$4.06M-$3.94M-$3.71M-$3.06M-$3.17M-$2.95M-$2.85M
Shares outstanding324.42M323.52M320.95M317.87M314.72M311.88M308.63M307.96M
Cash flow statement
Operating cash flow-$341,859-$268,824-$418,535-$392,310-$153,969-$312,139$13,416-$212,008
Capital expenditure$71,208——-$1-$67,252$31,521$104,630—
Free cash flow-$413,067——-$392,309-$86,717-$343,660-$91,214—
Investing cash flow-$95,208-$47,801-$10,000-$10,184$66,137-$38,668-$154,630-$85,561
Financing cash flow$421,500$330,000$372,000$372,500$175,000$351,250$100,000$197,000
Depreciation & amortization$26,407$28,974$31,377$18,412$30,339$30,198$29,926$29,663
Stock-based compensation$890,834$388,530$76,855$202,354$258,562$351,322$88,165$1.21M

Free plan shows the latest 8 periods; Pro shows all 52 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.